Picture of Propanc Biopharma logo

PPCB Propanc Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Propanc Biopharma Updates On Preparation Of PRP And Its Recently Completed Reverse Stock Split

July 15 (Reuters) - Propanc Biopharma Inc  PPCBD.PK :
    * PROPANC BIOPHARMA PROVIDES UPDATE ON PREPARATION OF PRP
FOR
CLINICAL TRIAL APPLICATION SUBMISSION AND RECENTLY COMPLETED
REVERSE STOCK SPLIT
    * PROPANC BIOPHARMA INC - PLANS TO SUBMIT ITS FIRST CLINICAL
TRIAL
APPLICATION IN SECOND HALF OF 2019
    * PROPANC BIOPHARMA INC - PLANS TO COMMENCE FIH STUDY IN
ADVANCED
CANCER PATIENTS FOR PRP DURING FIRST HALF OF 2020

Source text for Eikon:  ID:nBwc25Jjra 
Further company coverage:  PPCBD.PK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Propanc Biopharma

See all news